{"count": 86, "results": [{"_id": "37551050", "pmid": 37551050, "pmcid": "PMC10497034", "title": "Amlodipine in the current management of hypertension", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Wang JG", "Palmer BF", "Vogel Anderson K", "Sever P"], "date": "2023-08-07T00:00:00Z", "doi": "10.1111/jch.14709", "meta_date_publication": "2023 Aug 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50277.18, "text_hl": "Many landmark trials have shown the benefit of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ protection against @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@. ", "citations": {"NLM": "Wang JG, Palmer BF, Vogel Anderson K, Sever P. Amlodipine in the current management of hypertension J Clin Hypertens (Greenwich). 2023 Aug 7;():. PMID: 37551050", "BibTeX": "@article{37551050, title={Amlodipine in the current management of hypertension}, author={Wang JG and Palmer BF and Vogel Anderson K and Sever P}, journal={J Clin Hypertens (Greenwich)}}"}}, {"_id": "34480745", "pmid": 34480745, "pmcid": "PMC8555097", "title": "Effect of Amlodipine in Stroke and Myocardial infarction: A Systematic Review and Meta-analysis", "journal": "Cardiol Ther", "authors": ["Iyengar SS", "Mohan JC", "Ray S", "Rao MS", "Khan MY", "Patted URH", "Gaurav K"], "date": "2021-12-01T00:00:00Z", "doi": "10.1007/s40119-021-00239-1", "meta_date_publication": "2021 Dec", "meta_volume": "10", "meta_issue": "2", "meta_pages": "429-444", "score": 50269.645, "text_hl": "a Forest plot of risk ratio (RR) of @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ (@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ vs. other drugs), b Forest plot of RR of @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ (@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ vs. placebo)", "citations": {"NLM": "Iyengar SS, Mohan JC, Ray S, Rao MS, Khan MY, Patted URH, Gaurav K. Effect of Amlodipine in Stroke and Myocardial infarction: A Systematic Review and Meta-analysis Cardiol Ther. 2021 Dec;10(2):429-444. PMID: 34480745", "BibTeX": "@article{34480745, title={Effect of Amlodipine in Stroke and Myocardial infarction: A Systematic Review and Meta-analysis}, author={Iyengar SS and Mohan JC and Ray S and Rao MS and Khan MY and Patted URH and Gaurav K}, journal={Cardiol Ther}, volume={10}, number={2}, pages={429-444}}"}}, {"_id": "32854138", "pmid": 32854138, "pmcid": "PMC8049076", "title": "Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study", "journal": "J Intern Med", "authors": ["Kalar I", "Xu H", "Secnik J", "Schwertner E", "Kramberger MG", "Winblad B", "von Euler M", "Eriksdotter M", "Garcia-Ptacek S"], "date": "2021-04-01T00:00:00Z", "doi": "10.1111/joim.13170", "meta_date_publication": "2021 Apr", "meta_volume": "289", "meta_issue": "4", "meta_pages": "508-522", "score": 50265.805, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ was associated with lower @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ risk in @SPECIES_9606 @@@patients@@@ with @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's dementia@@@ compared to other CCBs (aHR 0.63; CI, 0.44-0.89; P < 0.05).", "citations": {"NLM": "Kalar I, Xu H, Secnik J, Schwertner E, Kramberger MG, Winblad B, von Euler M, Eriksdotter M, Garcia-Ptacek S. Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study J Intern Med. 2021 Apr;289(4):508-522. PMID: 32854138", "BibTeX": "@article{32854138, title={Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study}, author={Kalar I and Xu H and Secnik J and Schwertner E and Kramberger MG and Winblad B and von Euler M and Eriksdotter M and Garcia-Ptacek S}, journal={J Intern Med}, volume={289}, number={4}, pages={508-522}}"}}, {"_id": "32637107", "pmid": 32637107, "pmcid": "PMC7315662", "title": "A possible increase in liver enzymes due to amlodipine: A case report", "journal": "SAGE Open Med Case Rep", "authors": ["Varghese G", "Madi L", "Ghannam M", "Saad R"], "date": "2020-06-24T00:00:00Z", "doi": "10.1177/2050313X20917822", "meta_date_publication": "2020", "meta_volume": "8", "meta_issue": "", "meta_pages": "2050313X20917822", "score": 50260.48, "text_hl": "Here, we present a 47-year-old male @SPECIES_9606 @@@patient@@@ known to be @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ and admitted to our rehabilitation facility after an @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@acute stroke@@@. During his stay, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ was started in addition to other antihypertensive medications to control his blood pressure. ", "citations": {"NLM": "Varghese G, Madi L, Ghannam M, Saad R. A possible increase in liver enzymes due to amlodipine: A case report SAGE Open Med Case Rep. 2020;8():2050313X20917822. PMID: 32637107", "BibTeX": "@article{32637107, title={A possible increase in liver enzymes due to amlodipine: A case report}, author={Varghese G and Madi L and Ghannam M and Saad R}, journal={SAGE Open Med Case Rep}, volume={8}, pages={2050313X20917822}}"}}, {"_id": "34192893", "pmid": 34192893, "pmcid": "PMC8478091", "title": "Long-Term Incidence of Stroke and Dementia in ASCOT", "journal": "Stroke", "authors": ["Whiteley WN", "Gupta AK", "Godec T", "Rostamian S", "Whitehouse A", "Mackay J", "Sever PS"], "date": "2021-10-01T00:00:00Z", "doi": "10.1161/STROKEAHA.120.033489", "meta_date_publication": "2021 Oct", "meta_volume": "52", "meta_issue": "10", "meta_pages": "3088-3096", "score": 50257.79, "text_hl": "In conclusion, we demonstrate the importance of BP control with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ rather than @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ for @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ prevention and that starting @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ about 5 years earlier still has an important detectable effect on @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ incidence over 20 years. ", "citations": {"NLM": "Whiteley WN, Gupta AK, Godec T, Rostamian S, Whitehouse A, Mackay J, Sever PS. Long-Term Incidence of Stroke and Dementia in ASCOT Stroke. 2021 Oct;52(10):3088-3096. PMID: 34192893", "BibTeX": "@article{34192893, title={Long-Term Incidence of Stroke and Dementia in ASCOT}, author={Whiteley WN and Gupta AK and Godec T and Rostamian S and Whitehouse A and Mackay J and Sever PS}, journal={Stroke}, volume={52}, number={10}, pages={3088-3096}}"}}, {"_id": "33041135", "pmid": 33041135, "title": "Efficacy of methylene blue in a murine model of amlodipine overdose.", "journal": "Am J Emerg Med", "authors": ["de Castro Brás LE", "Baccanale CL", "Eccleston L", "Sloan T", "St Antoine JC", "Verzwyvelt SM", "Pittman P", "O'Rourke D", "Meggs WJ"], "date": "2021-07-01T00:00:00Z", "doi": "10.1016/j.ajem.2020.08.077", "meta_date_publication": "2021 Jul", "meta_volume": "45", "meta_issue": "", "meta_pages": "284-289", "score": 50255.06, "text_hl": "RESULTS: Only 50% of control animals survived to the two-hour endpoint compared to 83% that received @CHEMICAL_Methylene_Blue @CHEMICAL_MESH:D008751 @@@methylene blue@@@. @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ delivery induced significant reduction in left ventricular ejection fraction (EF), fractional shortening (FS), @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ volume (SV), and cardiac output (CO) in the vehicle treated animals relative to animals in the treatment group (p < 0.05 vehicle versus @CHEMICAL_Methylene_Blue @CHEMICAL_MESH:D008751 @@@Methylene blue@@@ for EF, FS, SV, CO, and HR). ", "citations": {"NLM": "de Castro Brás LE, Baccanale CL, Eccleston L, Sloan T, St Antoine JC, Verzwyvelt SM, Pittman P, O'Rourke D, Meggs WJ. Efficacy of methylene blue in a murine model of amlodipine overdose. Am J Emerg Med. 2021 Jul;45():284-289. PMID: 33041135", "BibTeX": "@article{33041135, title={Efficacy of methylene blue in a murine model of amlodipine overdose.}, author={de Castro Brás LE and Baccanale CL and Eccleston L and Sloan T and St Antoine JC and Verzwyvelt SM and Pittman P and O'Rourke D and Meggs WJ}, journal={Am J Emerg Med}, volume={45}, pages={284-289}}"}}, {"_id": "32862551", "pmid": 32862551, "title": "Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia.", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Lin CP", "Tung YC", "Hsiao FC", "Yang CH", "Kao YW", "Lin YS", "Chu YC", "Chu PH"], "date": "2020-10-01T00:00:00Z", "doi": "10.1111/jch.14016", "meta_date_publication": "2020 Oct", "meta_volume": "22", "meta_issue": "10", "meta_pages": "1846-1853", "score": 50247.742, "text_hl": "Fixed-dose combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ improves clinical outcomes in @SPECIES_9606 @@@patients@@@ with concomitant @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@.", "citations": {"NLM": "Lin CP, Tung YC, Hsiao FC, Yang CH, Kao YW, Lin YS, Chu YC, Chu PH. Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia. J Clin Hypertens (Greenwich). 2020 Oct;22(10):1846-1853. PMID: 32862551", "BibTeX": "@article{32862551, title={Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia.}, author={Lin CP and Tung YC and Hsiao FC and Yang CH and Kao YW and Lin YS and Chu YC and Chu PH}, journal={J Clin Hypertens (Greenwich)}, volume={22}, number={10}, pages={1846-1853}}"}}, {"_id": "35932912", "pmid": 35932912, "title": "Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial.", "journal": "Am Heart J", "authors": ["Wang SY", "Hanna JM", "Gongal P", "Onuma OK", "Nanna MG"], "date": "2022-12-01T00:00:00Z", "doi": "10.1016/j.ahj.2022.07.006", "meta_date_publication": "2022 Dec", "meta_volume": "254", "meta_issue": "", "meta_pages": "30-34", "score": 50239.6, "text_hl": "We compared the use of @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, or @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on the primary outcome of combined @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@, @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@, or all-cause mortality in @SPECIES_9606 @@@patients@@@ with isolated @DISEASE_Isolated_Systolic_Hypertension @DISEASE_MESH:D000092244 @@@systolic hypertension@@@ or isolated @DISEASE_Hypertension_Diastolic_Resistance_to @DISEASE_MESH:C563897 @@@diastolic hypertension@@@.", "citations": {"NLM": "Wang SY, Hanna JM, Gongal P, Onuma OK, Nanna MG. Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial. Am Heart J. 2022 Dec;254():30-34. PMID: 35932912", "BibTeX": "@article{35932912, title={Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial.}, author={Wang SY and Hanna JM and Gongal P and Onuma OK and Nanna MG}, journal={Am Heart J}, volume={254}, pages={30-34}}"}}, {"_id": "32336236", "pmid": 32336236, "title": "Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers.", "journal": "Hypertension", "authors": ["Mehlum MH", "Liestøl K", "Kjeldsen SE", "Wyller TB", "Julius S", "Rothwell PM", "Mancia G", "Parati G", "Weber MA", "Berge E"], "date": "2020-06-01T00:00:00Z", "doi": "10.1161/HYPERTENSIONAHA.119.14443", "meta_date_publication": "2020 Jun", "meta_volume": "75", "meta_issue": "6", "meta_pages": "1584-1592", "score": 50239.227, "text_hl": "In conclusion, the higher risks of @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ and @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ in @SPECIES_9606 @@@patients@@@ randomized to @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ versus @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ were related to the drugs' different blood pressure modulating profiles. ", "citations": {"NLM": "Mehlum MH, Liestøl K, Kjeldsen SE, Wyller TB, Julius S, Rothwell PM, Mancia G, Parati G, Weber MA, Berge E. Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers. Hypertension. 2020 Jun;75(6):1584-1592. PMID: 32336236", "BibTeX": "@article{32336236, title={Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers.}, author={Mehlum MH and Liestøl K and Kjeldsen SE and Wyller TB and Julius S and Rothwell PM and Mancia G and Parati G and Weber MA and Berge E}, journal={Hypertension}, volume={75}, number={6}, pages={1584-1592}}"}}, {"_id": "34994269", "pmid": 34994269, "title": "Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress.", "journal": "Int J Stroke", "authors": ["Anderson CS", "Rodgers A", "de Silva HA", "Martins SO", "Klijn CJ", "Senanayake B", "Freed R", "Billot L", "Arima H", "Thang NH", "Zaidi WAW", "Kherkheulidze T", "Wahab K", "Fisher U", "Lee TH", "Chen C", "Pontes-Neto O", "Robinson T", "Wang J", "Naismith S", "Song L", "Schreuder FH", "Lindley RI", "Woodward M", "MacMahon S", "Salman RA", "Chow CK", "Chalmers J"], "date": "2022-12-01T00:00:00Z", "doi": "10.1177/17474930211068671", "meta_date_publication": "2022 Dec", "meta_volume": "17", "meta_issue": "10", "meta_pages": "1156-1162", "score": 50232.86, "text_hl": "OBJECTIVES: The Triple Therapy Prevention of Recurrent @DISEASE_Cerebral_Hemorrhage @DISEASE_MESH:D002543 @@@Intracerebral Disease@@@ Events Trial (TRIDENT) aims to determine the effects of a novel SPC \"Triple Pill,\" three generic antihypertensive drugs with demonstrated efficacy and complementary mechanisms of action at half standard dose (@CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ 20 mg, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 2.5 mg, and @CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@ 1.25 mg), with placebo for the prevention of recurrent @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@, cardiovascular events, and @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@cognitive impairment@@@ after @DISEASE_Cerebral_Hemorrhage @DISEASE_MESH:D002543 @@@ICH@@@. ", "citations": {"NLM": "Anderson CS, Rodgers A, de Silva HA, Martins SO, Klijn CJ, Senanayake B, Freed R, Billot L, Arima H, Thang NH, Zaidi WAW, Kherkheulidze T, Wahab K, Fisher U, Lee TH, Chen C, Pontes-Neto O, Robinson T, Wang J, Naismith S, Song L, Schreuder FH, Lindley RI, Woodward M, MacMahon S, Salman RA, Chow CK, Chalmers J. Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress. Int J Stroke. 2022 Dec;17(10):1156-1162. PMID: 34994269", "BibTeX": "@article{34994269, title={Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress.}, author={Anderson CS and Rodgers A and de Silva HA and Martins SO and Klijn CJ and Senanayake B and Freed R and Billot L and Arima H and Thang NH and Zaidi WAW and Kherkheulidze T and Wahab K and Fisher U and Lee TH and Chen C and Pontes-Neto O and Robinson T and Wang J and Naismith S and Song L and Schreuder FH and Lindley RI and Woodward M and MacMahon S and Salman RA and Chow CK and Chalmers J}, journal={Int J Stroke}, volume={17}, number={10}, pages={1156-1162}}"}}]}